Breaking News Instant updates and real-time market news.

ABBV

AbbVie

$73.18

1.84 (2.58%)

08:49
06/23/17
06/23
08:49
06/23/17
08:49

AbbVie receives CHMP positive opinion for MAVIRET

AbbVie announced that the European Committee for Medicinal Products for Human Use of the European Medicines Agency has granted a positive opinion recommending marketing authorization of MAVIRET, an investigational, pan-genotypic treatment for adults with chronic hepatitis C virus infection. If approved, MAVIRET will be a once-daily, ribavirin-free, 8-week option for patients without cirrhosis and who are new to treatment across all genotypes, who comprise the majority of people living with HCV.1 The European Commission will now review the CHMP opinion and a final decision is expected in Q3 2017.

ABBV AbbVie
$73.18

1.84 (2.58%)

06/12/17
LEER
06/12/17
NO CHANGE
Target $90
LEER
Outperform
Eli Lilly price target lowered to $90 from $93 at Leerink
Leerink analyst Seamus Fernandez lowered his price target for Eli Lilly (LLY) to $90 to reflect reduced sales forecasts for baricitinib, an oral JAK1/2 inhibitor to treat rheumatoid arthritis which the company collaborates with Incyte (INCY). Following AbbVie's (ABBV) positive Phase 3 data last week for its JAK1 inhibitor upadacitinib, Fernandez dropped his U.S. peak sales estimate for baricitinib by more than 50% to $400M and pushed out his U.S. launch time to 2020 from 2018. The analyst keeps an Outperform rating on Lilly shares.
06/12/17
RHCO
06/12/17
NO CHANGE
RHCO
AbbVie should be bought on weakness, says SunTrust
SunTrust analyst John Boris says that AbbVie should be bought on weakness after the USPTO invalidated two of the company's patents for Humira. The analyst says that the ruling "makes a small dent" in the company's IP for Humira, as he notes that the company has more than 100 patents for the drug. He thinks that Humira biosimilars will enter the market later than the Street expects. Boris, maintaining that the company has over a dozen pipeline catalysts this year, recommends buying the shares on weakness.
06/22/17
LEER
06/22/17
NO CHANGE
LEER
Leerink sees reasons for biotech rally to continue
Leerink analyst Geoffrey Porges attributes the recent strength in the biotech sector to a lessening of the perceived fears of pricing regulations and a favorable tone from the FDA. However, he believes the sector could advance at least 15% more, as he foresees more positive operating results and still expects more industry consolidation. Among large cap biotech names, Porges maintains Outperform ratings on Regeneron (REGN), Celgene (CELG), Vertex (VRTX) and Alexion(ALXN) and keeps Market Perform ratings on AbbVie (ABBV), Amgen (AMGN), Gilead (GILD) and Biogen (BIIB).
06/22/17
SOCG
06/22/17
UPGRADE
SOCG
Buy
AbbVie upgraded to Buy from Hold at Societe Generale

TODAY'S FREE FLY STORIES

10:25
08/18/17
08/18
10:25
08/18/17
10:25
General news
Treasury Action: yields steadied above lows »

Treasury Action: yields…

10:25
08/18/17
08/18
10:25
08/18/17
10:25
Conference/Events
Cowen Washington strategist holds analyst/industry conference call »

Washington Research Group…

HPE

HP Enterprise

$17.11

-0.19 (-1.10%)

10:20
08/18/17
08/18
10:20
08/18/17
10:20
Options
Repeat option activity in Hewlett Packard Enterprises »

Repeat option activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

10:20
08/18/17
08/18
10:20
08/18/17
10:20
General news
The Michigan sentiment pop to 97.6 »

The Michigan sentiment…

MDU

MDU Resources

$25.82

0.01 (0.04%)

10:18
08/18/17
08/18
10:18
08/18/17
10:18
Syndicate
Breaking Syndicate news story on MDU Resources »

MDU Resources files mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

10:17
08/18/17
08/18
10:17
08/18/17
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

10:16
08/18/17
08/18
10:16
08/18/17
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOSL

Fossil

$7.77

-0.09 (-1.15%)

10:15
08/18/17
08/18
10:15
08/18/17
10:15
Options
Fossil put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
08/18/17
08/18
10:15
08/18/17
10:15
General news
FX Action: The dollar »

FX Action: The dollar…

AMTD

TD Ameritrade

$42.44

-0.93 (-2.14%)

10:13
08/18/17
08/18
10:13
08/18/17
10:13
Conference/Events
TD Ameritrade management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 24

    Aug

  • 06

    Sep

DE

Deere

$113.40

-10.58 (-8.53%)

10:12
08/18/17
08/18
10:12
08/18/17
10:12
Hot Stocks
Deere says long term global tail winds for agricultural economy in place »

Comments are from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 22

    Nov

CTL

CenturyLink

$19.13

-0.25 (-1.29%)

, LVLT

Level 3

$52.64

-0.35 (-0.66%)

10:12
08/18/17
08/18
10:12
08/18/17
10:12
Recommendations
CenturyLink, Level 3 analyst commentary  »

CenturyLink and Level 3…

CTL

CenturyLink

$19.13

-0.25 (-1.29%)

LVLT

Level 3

$52.64

-0.35 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$197.16

-0.832 (-0.42%)

10:11
08/18/17
08/18
10:11
08/18/17
10:11
Hot Stocks
General Dynamics awarded $115.3M contract modification by Navy »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

10:05
08/18/17
08/18
10:05
08/18/17
10:05
General news
FX Action: USD-CAD »

FX Action: USD-CAD fell…

IWM

iShares Trust Russell 2000 Index Fund

$134.44

-0.49 (-0.36%)

, RUT

Russell 2000 Index

10:02
08/18/17
08/18
10:02
08/18/17
10:02
Technical Analysis
Technical View: Russell 2000 Index nears key technical levels »

The Russell 2000 (RUT) is…

IWM

iShares Trust Russell 2000 Index Fund

$134.44

-0.49 (-0.36%)

RUT

Russell 2000 Index

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:01
08/18/17
08/18
10:01
08/18/17
10:01
General news
Consumer Sentiment Index data reported »

Consumer Sentiment Index…

QQQ

PowerShares QQQ Trust

$141.33

-2.95 (-2.04%)

10:00
08/18/17
08/18
10:00
08/18/17
10:00
Options
Defensive spread in PowerShares QQQ »

Defensive spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:00
08/18/17
08/18
10:00
08/18/17
10:00
General news
Breaking General news story  »

Dallas Federal Reserve…

IMUC

ImmunoCellular

$0.32

-0.0191 (-5.65%)

09:56
08/18/17
08/18
09:56
08/18/17
09:56
Conference/Events
ImmunoCellular to host conference call »

Business News Update…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

ROST

Ross Stores

$53.33

-1.04 (-1.91%)

, EL

Estee Lauder

$102.49

4.165 (4.24%)

09:55
08/18/17
08/18
09:55
08/18/17
09:55
Options
Early notable gainers among liquid option names on August 18th »

Notable gainers among…

ROST

Ross Stores

$53.33

-1.04 (-1.91%)

EL

Estee Lauder

$102.49

4.165 (4.24%)

NEM

Newmont Mining

$37.16

1.11 (3.08%)

AMAT

Applied Materials

$43.12

-1.34 (-3.01%)

XEC

Cimarex Energy

$96.89

0.59 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 22

    Aug

  • 23

    Aug

DAL

Delta Air Lines

$47.54

0.01 (0.02%)

09:54
08/18/17
08/18
09:54
08/18/17
09:54
Upgrade
Delta Air Lines rating change  »

Follow-up: Delta Air…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LUV

Southwest

$53.41

0.26 (0.49%)

09:54
08/18/17
08/18
09:54
08/18/17
09:54
Upgrade
Southwest rating change  »

Follow-up: Southwest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWN

Southwestern Energy

09:50
08/18/17
08/18
09:50
08/18/17
09:50
Options
Opening action in Southwest Energy expiring puts »

Opening action in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 29

    Aug

  • 05

    Sep

HIBB

Hibbett Sports

$11.50

-0.3 (-2.54%)

09:47
08/18/17
08/18
09:47
08/18/17
09:47
Recommendations
Hibbett Sports analyst commentary  »

Hibbett Sports price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

MATX

Matson

$24.27

-5.08 (-17.31%)

09:46
08/18/17
08/18
09:46
08/18/17
09:46
Downgrade
Matson rating change  »

Matson downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.